LIMITED GUARANTEELimited Guarantee • November 20th, 2020 • CITIC Capital Holdings LTD • Biological products, (no disgnostic substances) • New York
This LIMITED GUARANTEE, dated as of November 19, 2020 (this “Limited Guarantee”), is made by CC China (2019B) L.P., an exempted limited partnership formed under the Laws of the Cayman Islands (the “Guarantor”), in favor of China Biologic Products Holdings, Inc., an exempted company incorporated with limited liability under the Laws of the Cayman Islands (the “Guaranteed Party”). This Limited Guarantee is being delivered to the Guaranteed Party concurrently with the execution and delivery of the Merger Agreement (as defined below). Unless otherwise defined herein, capitalized terms used herein shall have the meanings assigned to them in the Merger Agreement.
SHARE PURCHASE AGREEMENTShare Purchase Agreement • October 28th, 2020 • CITIC Capital Holdings LTD • Biological products, (no disgnostic substances) • New York
This SHARE PURCHASE AGREEMENT, dated as of October 26, 2020 (this “Agreement”), by and among PW Medtech Group Limited, a Cayman Islands company (the “Seller”) and 2019B Cayman Limited, an exempted company incorporated in the Cayman Islands with limited liability (the “Purchaser,” and together with the Seller, each a “Party” and collectively, the “Parties”). Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to them in Section 6.1 hereof.
SHARE PURCHASE AGREEMENT by and between CHINA BIOLOGIC PRODUCTS HOLDINGS, INC. and CITIC CAPITAL MB INVESTMENT LIMITED Dated as of August 24, 2018Share Purchase Agreement • August 27th, 2018 • CITIC Capital Holdings LTD • Biological products, (no disgnostic substances) • New York
THIS SHARE PURCHASE AGREEMENT, dated as of August 24, 2018 (this “Agreement”), is by and between China Biologic Products Holdings, Inc., a Cayman Islands exempted company (the “Company”), and CITIC Capital MB Investment Limited, a company organized and existing under the Laws of the Cayman Islands (the “Investor”). The Company and the Investor are referred to in this Agreement collectively as the “Parties” and individually as a “Party.”
INVESTOR RIGHTS AGREEMENTInvestor Rights Agreement • August 27th, 2018 • CITIC Capital Holdings LTD • Biological products, (no disgnostic substances) • New York
SHARE PURCHASE AGREEMENTShare Purchase Agreement • October 28th, 2020 • CITIC Capital Holdings LTD • Biological products, (no disgnostic substances) • New York
This SHARE PURCHASE AGREEMENT, dated as of October 26, 2020 (this “Agreement”), by and among Parfield International Ltd., a British Virgin Islands company (the “Seller”) and 2019B Cayman Limited, a Cayman Islands company (the “Purchaser,” and together with the Seller, each a “Party” and collectively, the “Parties”). Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to them in Section 6.1 hereof.
LETTER AGREEMENTLetter Agreement • October 28th, 2020 • CITIC Capital Holdings LTD • Biological products, (no disgnostic substances) • Hong Kong
This letter agreement (this “Letter Agreement”) sets forth the agreement by and among PW Medtech Group Limited, an exempted company with limited liability incorporated under the laws of the Cayman Islands (“PWM”), and 2019B Cayman Limited, an exempted company with limited liability incorporated under the laws of the Cayman Islands (“2019B Cayman,” and together with PWM, each a “Party” and collectively, the “Parties”) in relation to the Take Private Transaction (as defined below). It is contemplated that, (a) pursuant to that certain consortium agreement, dated as of September 18, 2019, by and among PWM and other parties thereto (as amended by amendment no. 1 thereto dated as of January 23, 2020 and by a letter agreement dated as of September 16, 2020, and as further amended, restated or modified from time to time, the “Consortium Agreement”), parties to the Consortium Agreement (including other parties that subsequently join thereto from time to time but excluding those that withdraw t
EQUITY COMMITMENT LETTERCITIC Capital Holdings LTD • November 20th, 2020 • Biological products, (no disgnostic substances) • New York
This letter agreement sets forth the commitment of CC China (2019B) L.P., a limited partnership formed under the Laws of the Cayman Islands (“Sponsor”), subject to the terms and conditions contained herein, to purchase, directly or indirectly, certain equity interests of CBPO Holdings Limited, an exempted company incorporated with limited liability under the Laws of the Cayman Islands (“Parent”). It is contemplated that, pursuant to that certain Agreement and Plan of Merger, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the “Merger Agreement”), by and among Parent, CBPO Group Limited, an exempted company incorporated with limited liability under the Laws of the Cayman Islands and a wholly owned subsidiary of Parent (“Merger Sub”) and China Biologic Products Holdings, Inc., an exempted company organized and existing under the Laws of the Cayman Islands (the “Company”), Merger Sub will merge with and into the Company (the “Merger
LETTER AGREEMENTLetter Agreement • October 28th, 2020 • CITIC Capital Holdings LTD • Biological products, (no disgnostic substances) • Hong Kong
This letter agreement (this “Letter Agreement”) sets forth the agreement by and among Parfield International Ltd., a British Virgin Islands company (“Parfield”), and 2019B Cayman Limited, an exempted company with limited liability incorporated under the laws of the Cayman Islands (“2019B Cayman”, and together with Parfield, each a “Party” and collectively, the “Parties”) in relation to the Take Private Transaction (as defined below). It is contemplated that, (a) pursuant to that certain consortium agreement, dated as of September 18, 2019, by and among Parfield and other parties thereto (as amended by amendment no. 1 thereto dated as of January 23, 2020 and as further amended, restated or modified from time to time, the “Consortium Agreement”), parties to the Consortium Agreement (including other parties that subsequently join thereto from time to time but excluding those that withdraw therefrom from time to time, the “Consortium”) have submitted a preliminary non-binding proposal, dat
JOINT FILING AGREEMENTJoint Filing Agreement • June 17th, 2016 • CITIC Capital Holdings LTD • Services-computer processing & data preparation
In accordance with Rule 13d-1(k) of the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including any and all additional amendments thereto) with respect to the ordinary shares of Bitauto Holdings Limited and further agree that this joint filing agreement (this “Agreement”) shall be included as an Exhibit to such joint filing. Each person further agrees as follows:
JOINT FILING AGREEMENTJoint Filing Agreement • April 8th, 2020 • CITIC Capital Holdings LTD • Biological products, (no disgnostic substances)
In accordance with Rule 13d-1(k) of the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including any and all additional amendments thereto) with respect to the ordinary shares of China Biologic Products Holdings, Inc. and further agree that this joint filing agreement (this “Agreement”) shall be included as an Exhibit to such joint filing. Each person further agrees as follows:
DEED OF ADHERENCEDeed of Adherence • October 16th, 2018 • CITIC Capital Holdings LTD • Biological products, (no disgnostic substances)
This Deed of Adherence (this “Deed”) is made as of the date written below by the undersigned (the “Joining Party”) in accordance with the Investor Rights Agreement dated as of August 24, 2018 (the “Investor Rights Agreement”) between China Biologic Products Holdings, Inc., a Cayman Islands exempted company, and CITIC Capital MB Investment Limited (the “Original Investor”), a Cayman Islands exempted company.
JOINT FILING AGREEMENTJoint Filing Agreement • November 21st, 2016 • CITIC Capital Holdings LTD • Services-computer processing & data preparation
In accordance with Rule 13d-1(k) of the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including any and all additional amendments thereto) with respect to the ordinary shares of Bitauto Holdings Limited and further agree that this joint filing agreement (this “Agreement”) shall be included as an Exhibit to such joint filing. Each person further agrees as follows:
JOINT FILING AGREEMENTJoint Filing Agreement • October 16th, 2018 • CITIC Capital Holdings LTD • Biological products, (no disgnostic substances)
In accordance with Rule 13d-1(k) of the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including any and all additional amendments thereto) with respect to the ordinary shares of China Biologic Products Holdings, Inc. and further agree that this joint filing agreement (this “Agreement”) shall be included as an Exhibit to such joint filing. Each person further agrees as follows:
JOINT FILING AGREEMENTJoint Filing Agreement • June 18th, 2018 • CITIC Capital Holdings LTD • Biological products, (no disgnostic substances)
In accordance with Rule 13d-1(k) of the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including any and all additional amendments thereto) with respect to the ordinary shares of China Biologic Products Holdings, Inc. and further agree that this joint filing agreement (this “Agreement”) shall be included as an Exhibit to such joint filing. Each person further agrees as follows:
